Investor Ideas #Potcasts; #Cannabis News and #Stocks on the Move; (TSXV: $KHRN.V) (TSXV: $HVT.V) (CSE: $HBOR.C) (CSE: $BHNG.C) (TSXV: $ELXR.V)
Delta, Kelowna, BC, December 4, 2019 (Investorideas.com Newswire) www.Investorideas.com, a global news source covering leading sectors including marijuana and hemp stocks and its potcast site, www.potcasts.ca release today’s podcast edition of cannabis news and stocks to watch plus insight from thought leaders and experts.
Listen to the podcast:
Read this in full at https://www.investorideas.com/news/2019/cannabis-potcasts/12041KHRN-HVT-HBOR-BHNG-ELXR.asp
Today’s podcast overview/transcript:
Good afternoon and welcome to another episode of Investorideas.com "Potcast" featuring cannabis news, stocks to watch as well as insights from thought leaders and experts.
In today’s podcast we look at a few early announcements.
But first, according to a recent study, Cannabis consumers are deeply concerned with the use of chemical pesticides and fertilization and the environmental impact resulting from the cultivation process, and are calling for new product standards to ensure safety, freshness and efficacy, a new study in legalized states shows.
Canivate Growing Systems Ltd. (www.thecanivateway.com), conducted a U.S. nationwide survey of more than 600 cannabis consumers in states where adult cannabis purchase is legal. The survey found consumers overwhelmingly support establishing both environmental standards (79% supporting) and quality certifications (77%) for adult recreational cannabis products.
Respondents indicated that they are willing to pay more for cannabis that is grown in an eco-friendly, organic manner, with 64% of respondents agreeing. But when asked about specific cultivation methods, that support increased dramatically. Consumers strongly favor paying more for cannabis that is:
- grown free from chemical pesticides (92%),
- without chemical fertilizers (88%),
- hasn't been irradiated for pathogens (85%),
- is grown in a low carbon footprint environment (82.5%), and
- cultivated in a manner that conserves water (86%).
"The research suggests that consumers are more sophisticated and discerning in their brand trust than was previously thought," said Troy McCellan, CEO of Canivate. "We believe new approaches to cultivation and testing are needed to preserve trust in this new market. The more educated consumers become, the more they will demand products that are environmentally friendly and certifiably proven to be free of chemical toxins, pathogens and decontamination treatments."
Khiron Life Sciences Corp. (TSXV: KHRN) (OTCQB: KHRNF) welcomes today's announcement from ANVISA, the National Agency for Health Surveillance of Brazil, establishing a legalized environment for the sale and consumption of cannabis for medical use. The new regulations will be published in the coming days on the Federal Official Gazette and enter into law 90 days after that.
In the announcement from ANVISA, a new class of medical cannabis-based products will be prescribed by doctors and sold through pharmacies, enabling patient safe and legal access. The regulatory framework sets a comprehensive procedure for the manufacture and import of these products as well as the requirements for commercialization, prescription, dispensing, monitoring and supervision of cannabis products for medical purposes. The resolution was approved unanimously and is valid for an initial three-year term.
Andres Galofre, Khiron Co-founder and Vice President, Business Development, commented, "We congratulate legislators and the health authority in Brazil for their leadership in establishing a legalized environment for medical cannabis in the country. With a population of over 200 million this will directly benefit the health and wellbeing of a significant number of patients in Brazil and affirms our position as a LatAm leader in a rapidly globalizing cannabis market."
Khiron has a firmly established market-entry strategy for Brazil, with Dormul S.A., its wholly owned subsidiary based in Uruguay giving the Company access to the Brazilian market through the Mercosur Regional Trading Bloc. The Company has initiated pre-clinical medical cannabis studies with the Universidad de la República of Uruguay and Institut Pasteur de Montevideo, providing direct strategic opportunity for 3 million patients for medical cannabis in Uruguay, and a Brazilian market of 3.4 million (New Frontier Data). Further, on November 29th the Company announced it had received authorization from the Colombian Technical Quotas Group ("TQG") for the commercialization of medical use High THC cannabis for domestic and export purposes, including to Brazil, with manufacture to begin in Q1 2020.
Harvest One Cannabis Inc. (TSX-V: HVT) (OTCQX: HRVOF) announced that its wholly-owned subsidiary and Licensed Producer United Greeneries Ltd. has entered into an agreement with Alberta Gaming, Liquor & Cannabis Commission to supply Captain's ChoiceTM and Royal HighTM branded cannabis throughout the province.
"This agreement with Alberta represents our fifth provincial supply agreement providing another distribution channel for our premium cannabis products," said Grant Froese, Chief Executive Officer of Harvest One. "This is an important partnership for Harvest One, as Alberta has the most robust provincial retail network with over 330 store fronts and one of the largest adult-use cannabis sales to date."
Under the terms of the agreement, United Greeneries will initially launch five varieties of Royal HighTM branded cannabis in whole-flower format as well as two varieties of Captain's ChoiceTM branded pre-rolled product for sale across Alberta in licensed cannabis stores. The Company is also working towards listing new product categories such as oils, vapes and topicals, to be made available for sale across the province.
United Greeneries produces curated strains of cannabis at its facility located in Duncan, British Columbia and through its cultivation agreement with Stevens Green in Ontario. United Greeneries' cannabis is consistently regarded as a high quality and sought-after product and is now available in five provinces; Ontario, British Columbia, Alberta, Manitoba and Saskatchewan.
Alberta is home to over 330 licensed cannabis stores fronts which represents the largest number of retail outlets in any province in the country. Harvest One will continue to seek new markets for both existing cannabis flower products as well as new cannabis infused products where regulations allow.
Harborside Inc. (CSE: HBOR), a California-focused, vertically-integrated cannabis enterprise, today announced the Grand Opening of their newest dispensary in Desert Hot Springs, this Saturday. The store is Harborside's first retail location outside of the Bay Area and will also be the first drive-thru dispensary in Southern California. Harborside co-founder Steve DeAngelo, local elected officials and other surprise celebrity guests will officially open the dispensary and drive-thru at a public celebration this Saturday.
The 4,800 square foot facility is strategically located on Interstate 10 between Los Angeles and Coachella and will carry both medical and adult-use products, including Harborside's own KEY line of cannabis products. In addition to its highly anticipated drive-thru, the Desert Hot Springs location will partner with Pure Healing Clinic, offering professional acupuncture, herbal medicine and other wellness services. This latest expansion marks Harborside's fourth retail operation in California.
"Harborside is committed to bringing exceptional cannabis products to our neighboring communities, and is proud to provide the Southern California market with best-in-class service and convenience," said Peter Bilodeau, interim CEO of Harborside. "We are especially pleased to have obtained one of the few drive-thru dispensary licenses in Southern California."
"Harborside decided to come to the Coachella Valley because we like to be where the action is," said co-founder and Chairman Emeritus Steve DeAngelo. "The Valley is growing into a world-class center of both the cannabis industry and cannabis tourism, so it's an ideal location to introduce the legendary Harborside retail model and in-house brands to a wider population. We're also bringing some things that the Valley hasn't seen yet, like our drive-thru, an on-site holistic healing clinic, and the legendary knowledge and compassion of our associates."
Bhang Inc. (CSE: BHNG) (OTCQX: BHNGF), a global cannabis CPG brand company with an extensive, award-winning portfolio of products, announced today that Jamie L. Pearson, Bhang’s Interim President, will assume the role of President & CEO, overseeing day-to-day management and strategic initiatives. Scott Van Rixel has stepped down as CEO.
“I am pleased to announce Jamie’s promotion to both President & CEO of Bhang. Jamie has shown considerable strength in her role as President and her work to develop a vision for Bhang’s future. I am confident that Jamie has the necessary skills to lead Bhang and execute our business objectives,” said Scott Van Rixel.
Bhang has issued a letter to its shareholders from Ms. Pearson, providing commentary on the Company's recent developments and upcoming objectives.
The Company is also proud to announce that Jamie was selected as one of the 2019 High Times Female Top 50. The award honors the 50 most influential women across the cannabis landscape, from activists, executives, and scientists, patients, and politicians. The honorees were selected by the brand’s editorial leadership from a pool of over 7,500 public nominations. High Times further honored Jamie by asking her to give the keynote address entitled ‘Breaking the Glass Ceiling’ to the honorees and approximately 300 people on November 13 at the Beverly Wilshire Hotel in California. A copy of her speech can be found on Bhang’s website HERE along with a copy of the full letter below.
Below are some of the highlights from Pearson’s letter to the shareholders.
“Over the past decade, Bhang has become one of the most-recognized brands in cannabis and central to our thesis is our low CAPEX/OPEX operating platform. We do not need to own multi-million-dollar greenhouses, massive production facilities or extravagant retail operations. Our capital-light business model has enabled us to be quick and nimble and is clearly a differentiator. Bhang’s focus is on being a great CPG company – period. We offer excellent products that consumers want and use top-tier manufacturing and distribution partners to get these products into consumers’ hands.”
“Our approach going forward will be to focus on reducing expenses and increasing revenues across product verticals that fall into our food/beverage, lifestyle, and wellness categories. I am pleased to provide the following update on existing and upcoming Bhang initiatives:”
Pearson also went on to discuss the company’s CBD Domestic & Global Distribution, CBD Brokerage, E-Commerce, Red Ace Organics and their THC Licensing Revenue Streams and Deep Manufacturing/Distribution Relationships in Nevada, Florida, Ohio, Michigan, Illinois and Canada.
Elixxer Ltd. (TSX-V: ELXR) (OTCQB: ELXIF) announced that Global Canna Labs has successfully exported 10 kilograms of medical cannabis from Jamaica into Canada.
This shipment of medical cannabis, the largest of its kind known to date, is a significant step forward in the development of Jamaica’s medical, therapeutic and scientific cannabis industry. The Caribbean Licensing Authority, CLA, has been working diligently on creating a viable export platform. Jamaica’s Minister of Industry, Commerce, Agriculture and Fisheries, the Honorable Audley Shaw applauded the news as he recently presented at the CanEx Investment Summit in Toronto on November 28th.
For further information please refer to: Jamaican Observer, December 4th, 2019:
Investor ideas reminds all listeners to read our disclaimers and disclosures on the
Investorideas.com website and this podcast is not an endorsement to buy products or services or securities. Investors are reminded all investment involves risk and possible loss of investment
Learn more about our cannabis podcasts at https://www.investorideas.com/Audio/Potcasts.asp
Investorideas.com podcasts are also available on iTunes, Spotify, Google Play Music, Stitcher, Spreaker, YouTube via Spreaker, iHeartradio and Tunein.
Potcasts is now a certified word mark Trademark on the blockchain through Cognate, Inc. CM Certification-Registration Number: 10468217708
About Investorideas.com - News that Inspires Big Investing Ideas
Investorideas.com is a recognized news source publishing third party news, research and original financial content. Learn about investing in stocks and sector trends with our news alerts, articles, podcasts and videos, looking at cannabis, crypto, AI and IoT, mining, sports biotech, water, renewable energy and more. Investor Idea’s original branded content includes the following podcasts and columns : Crypto Corner , Play by Play sports and stock news column, Investor Ideas Potcasts Cannabis News and Stocks on the Move podcast and column, Cleantech and Climate Change , Exploring Mining the AI Eye .
Disclaimer/Disclosure: Investorideas.com is a digital publisher of third party sourced news, articles and equity research as well as creates original content, including video, interviews and articles. Original content created by investorideas is protected by copyright laws other than syndication rights. Our site does not make recommendations for purchases or sale of stocks, services or products. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investing involves risk and possible losses. This site is currently compensated for news publication and distribution, social media and marketing, content creation and more. Disclosure is posted for each compensated news release, content published /created if required but otherwise the news was not compensated for and was published for the sole interest of our readers and followers. Contact management and IR of each company directly regarding specific questions.
More disclaimer info: https://www.investorideas.com/About/Disclaimer.asp Learn more about publishing your news release and our other news services on the Investorideas.com newswire https://www.investorideas.com/News-Upload/ and tickertagstocknews.com Global investors must adhere to regulations of each country. Please read Investorideas.com privacy policy: https://www.investorideas.com/About/Private_Policy.asp
Investor Ideas does not condone the use of cannabis except where permissible by law. Our site does not possess, distribute, or sell cannabis products.
Follow us on Cannabis Social Media
Contact Investorideas.com
800-665-0411
